One of the biggest challenges pharmaceutical companies face is with the time taken to discover new drugs, develop them and get them to market. This lengthy process is punctuated with false starts.

TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that as part of its strategic plan to ...

Frey is founder and chief innovation officer of Deep Genomics. In a time of relentless AI hype and mounting global economic uncertainty, the real winners will be those who think long-term. One of the ...

CAMBRIDGE, Mass. & TORONTO--(BUSINESS WIRE)--Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic medicines with its AI foundation model platform, today announced the ...

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, ...